Company patents
GAMBRO LUNDIA AB
GAMBRO LUNDIA AB's patent strategy is heavily concentrated in "Drug Delivery Devices," accounting for 76.4% of its portfolio, yet this core area saw a significant 19.4% decline in 2025 and a further 64.0% drop so far in 2026, suggesting a potential shift in focus despite a surge in 2024. Surprisingly, while "Healthcare Informatics" showed rapid growth of 160.0% in 2024, its subsequent decline of 15.4% in 2025 and 81.8% so far in 2026 indicates a fluctuating commitment to digital health, alongside a notable 400.0% growth in "Pharmaceutical Preparations" in 2024 which has since seen a sharp decline, with no patents so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
203 US filings (since 2023) · 8 categories · 15 themes
Hollow-fiber and flat-sheet membranes for blood purification, hemodialysis, hemofiltration, and related extracorporeal therapies.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Membrane and depth filtration for industrial separation, gas purification, and bioprocess clarification including cross-flow, dead-end, tangential flow filtration, and oil/water separation.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Membrane-based separation for water purification, contaminant removal, desalination, and wastewater treatment, including reverse osmosis, ultrafiltration, and forward osmosis modules.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Systems and methods specifically engineered for removing pollutants and impurities from water sources, ranging from groundwater decontamination to point-of-use filtration, often employing adsorption, membrane, or distillation techniques.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Development of materials with tailored porosity, surface chemistry, or structure, such as metal-organic frameworks (MOFs), zeolites, or superficially porous particles, for selective adsorption, ion exchange, or chromatographic separations.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Non-chemical or non-biological methods that alter the physical properties or structure of water, often claimed to improve its quality or interaction with biological systems, such as vortexing or electromagnetic treatment.
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Technologies and systems for removing unwanted components or separating desired gases from a mixed gas stream, including adsorption, absorption, and membrane-based methods.
Processes that use strong oxidants, electrochemical methods, sonic waves, or other energy-intensive techniques to break down organic pollutants, disinfect water, or facilitate contaminant separation.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Patents
Showing 1-10 of 338